Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $8.23 billion. The enterprise value is $9.96 billion.
Important Dates
The next confirmed earnings date is Thursday, May 1, 2025, after market close.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 185.76 million shares outstanding. The number of shares has increased by 2.25% in one year.
Current Share Class | 185.76M |
Shares Outstanding | 185.76M |
Shares Change (YoY) | +2.25% |
Shares Change (QoQ) | +0.28% |
Owned by Insiders (%) | 0.75% |
Owned by Institutions (%) | 100.09% |
Float | 184.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 129.27 |
PS Ratio | 2.96 |
Forward PS | 2.64 |
PB Ratio | 3.42 |
P/TBV Ratio | n/a |
P/FCF Ratio | 110.34 |
P/OCF Ratio | 39.07 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 334.77, with an EV/FCF ratio of 133.65.
EV / Earnings | n/a |
EV / Sales | 3.61 |
EV / EBITDA | 334.77 |
EV / EBIT | n/a |
EV / FCF | 133.65 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 1.16.
Current Ratio | 2.15 |
Quick Ratio | 1.76 |
Debt / Equity | 1.16 |
Debt / EBITDA | 38.74 |
Debt / FCF | 37.24 |
Interest Coverage | -6.85 |
Financial Efficiency
Return on equity (ROE) is -37.09% and return on invested capital (ROIC) is -2.12%.
Return on Equity (ROE) | -37.09% |
Return on Assets (ROA) | -1.87% |
Return on Invested Capital (ROIC) | -2.12% |
Return on Capital Employed (ROCE) | -3.56% |
Revenue Per Employee | $394,124 |
Profits Per Employee | -$146,980 |
Employee Count | 7,000 |
Asset Turnover | 0.44 |
Inventory Turnover | 5.80 |
Taxes
Income Tax | -7.30M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.95% in the last 52 weeks. The beta is 1.14, so Exact Sciences's price volatility has been higher than the market average.
Beta (5Y) | 1.14 |
52-Week Price Change | -39.95% |
50-Day Moving Average | 49.02 |
200-Day Moving Average | 55.76 |
Relative Strength Index (RSI) | 42.20 |
Average Volume (20 Days) | 1,960,854 |
Short Selling Information
The latest short interest is 10.60 million, so 5.71% of the outstanding shares have been sold short.
Short Interest | 10.60M |
Short Previous Month | 10.66M |
Short % of Shares Out | 5.71% |
Short % of Float | 5.75% |
Short Ratio (days to cover) | 4.05 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.76 billion and -$1.03 billion in losses. Loss per share was -$5.59.
Revenue | 2.76B |
Gross Profit | 1.92B |
Operating Income | -185.10M |
Pretax Income | -172.10M |
Net Income | -1.03B |
EBITDA | 29.76M |
EBIT | -185.10M |
Loss Per Share | -$5.59 |
Full Income Statement Balance Sheet
The company has $1.04 billion in cash and $2.78 billion in debt, giving a net cash position of -$1.74 billion or -$9.35 per share.
Cash & Cash Equivalents | 1.04B |
Total Debt | 2.78B |
Net Cash | -1.74B |
Net Cash Per Share | -$9.35 |
Equity (Book Value) | 2.40B |
Book Value Per Share | 12.94 |
Working Capital | 839.24M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $210.54 million and capital expenditures -$135.99 million, giving a free cash flow of $74.55 million.
Operating Cash Flow | 210.54M |
Capital Expenditures | -135.99M |
Free Cash Flow | 74.55M |
FCF Per Share | $0.40 |
Full Cash Flow Statement Margins
Gross margin is 69.55%, with operating and profit margins of -6.71% and -37.29%.
Gross Margin | 69.55% |
Operating Margin | -6.71% |
Pretax Margin | -37.56% |
Profit Margin | -37.29% |
EBITDA Margin | 1.08% |
EBIT Margin | -6.71% |
FCF Margin | 2.70% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.25% |
Shareholder Yield | -2.25% |
Earnings Yield | -12.51% |
FCF Yield | 0.91% |
Dividend Details Analyst Forecast
The average price target for Exact Sciences is $70.59, which is 59.42% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $70.59 |
Price Target Difference | 59.42% |
Analyst Consensus | Strong Buy |
Analyst Count | 18 |
Revenue Growth Forecast (5Y) | 10.09% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.32 |
Piotroski F-Score | 3 |